Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China · Delayed Price · Currency is CNY 4.890
-0.020 (-0.41%)
Nov 10, 2026, 3:04 PM CST
SHE:002252 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,201 | 7,348 | 8,176 | 7,964 | 6,567 | 4,288 |
Revenue Growth | -22.03% | -10.13% | 2.67% | 21.27% | 53.16% | 55.26% |
Gross Profit Gross Profit Growth | 2,192 | 2,690 | 3,304 | 3,229 | 2,889 | 2,219 |
Operating Income Operating Income Growth | 1,023 | 1,596 | 2,093 | 2,316 | 1,989 | 1,462 |
Net Income Net Income Growth | 1,085 | 1,577 | 2,193 | 1,779 | 1,880 | 1,295 |
Earnings Per Share EPS Growth | 0.17 | 0.24 | 0.33 | 0.27 | 0.28 | 0.19 |
EPS Growth | -39.90% | -27.35% | 22.22% | -3.19% | 46.80% | -8.09% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
East China East China Growth | 2,599 | 2,990 | 2,978 | 2,411 | 1,541 |
Southern China Southern China Growth | 1,545 | 1,689 | 1,856 | 1,595 | 1,035 |
Northern China Northern China Growth | 2,094 | 2,102 | 1,930 | 1,538 | 897.27 |
Northeast China Region Northeast China Region Growth | 264.7 | 384.13 | 298.3 | 251.66 | 172.13 |
Southwest Region Southwest Region Growth | 488.64 | 484.42 | 516.08 | 323 | 202.02 |
Northwestern Region Northwestern Region Growth | 304.93 | 470.48 | 363.76 | 279.67 | 167.32 |
Export Export Growth | 52.44 | 56.69 | 22.81 | 169.23 | 273.16 |
Total Total Growth | 7,348 | 8,176 | 7,964 | 6,567 | 4,288 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,189 | 2,107 | 2,983 | 4,198 | 4,216 | 2,966 |
Total Debt Total Debt Growth | 4,241 | 3,904 | 17.59 | 1.91 | 3.82 | 8.25 |
Net Cash (Debt) Net Cash Growth | -2,052 | -1,798 | 2,965 | 4,196 | 4,212 | 2,958 |
Net Cash Growth | - | - | -29.34% | -0.36% | 42.38% | 34.00% |
Net Cash Per Share Net Cash Per Share Growth | -0.31 | -0.27 | 0.45 | 0.64 | 0.62 | 0.44 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -835.44 | -328.69 | -482.06 | 2,278 | 1,726 | 1,294 |
Capital Expenditures CapEx Growth | -481.34 | -384.82 | -407.15 | -450.8 | -225.73 | -204.61 |
Free Cash Flow Free Cash Flow Growth | -1,317 | -713.52 | -889.2 | 1,827 | 1,500 | 1,089 |
Free Cash Flow Growth | - | - | - | 21.82% | 37.68% | 18.79% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 35.35% | 36.61% | 40.41% | 40.54% | 43.99% | 51.75% |
Operating Margin | 16.49% | 21.72% | 25.60% | 29.09% | 30.29% | 34.10% |
Pretax Margin | 21.79% | 25.93% | 32.04% | 27.68% | 34.62% | 35.89% |
Profit Margin | 17.50% | 21.46% | 26.82% | 22.34% | 28.63% | 30.19% |
FCF Margin | -21.23% | -9.71% | -10.88% | 22.94% | 22.84% | 25.41% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.048 | 0.048 | 0.070 | 0.030 | 0.030 | 0.028 |
Dividend Per Share Growth | 46.36% | -31.00% | 133.33% | 0% | 7.14% | 12.00% |
Dividend Yield | 0.99% | 0.76% | 0.97% | 0.37% | 0.47% | 0.41% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.60 | 26.55 | 21.74 | 29.88 | 22.73 | 35.51 |
Forward PE | - | 17.14 | 18.28 | 22.86 | 96.49 | 96.49 |
P/FCF Ratio | - | - | - | 29.10 | 28.49 | 42.20 |
PS Ratio | 5.20 | 5.70 | 5.83 | 6.68 | 6.51 | 10.72 |